Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Salesforce
CRM
5
American Express
AXP
No Data
Alnylam Pharmaceuticals Analyst Ratings
RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Cuts Target Price to $465
Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Ascendis Pharma (ASND)
Wells Fargo Maintains Alnylam Pharmaceuticals(ALNY.US) With Hold Rating, Cuts Target Price to $376
Alnylam Pharmaceuticals on Track for Lowest Close Since July -- Data Talk
A Look Into Alnylam Pharmaceuticals Inc's Price Over Earnings